Owkin raises €4.5M Series A round

23 May 2018· Paris, France· health, biotech, ai, b2b, pure_software

This extension round was used to support the development of AI-based decision-making tools for biopharma companies.

Investors

LeadGV

About Owkin

Stage
Bridge
Headquarters
Paris, France
Founded
2016
Team Size
201–500
Sectors
healthbiotechaib2bpure_software

Source: https://www.nasdaqprivatemarket.com/company/owkin/